BRP - a new GLP1-like peptide

GLP1 Receptor Agoinists are still the most well-researched type 2 diabetes and weight loss solutions that has been seen by modern science, but we like to keep an eye on what could be next.

Recently, there's been some news on BRINP2-related peptide ("BRP", colloquially), so we took a dive to learn more, starting with the article from MedicalXpress:

Naturally occurring molecule rivals Ozempic in weight loss, sidesteps side effects

A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide—also known as Ozempic—in suppressing appetite and reducing body weight. Notably, testing in animals also showed that it worked without some of the drug’s side effects, such as nausea, constipation and significant loss of muscle mass.

Medical XpressKrista Conger

Krista wrote the article here and the one at Stanford's main site (but we'll get to that later):

Naturally occurring molecule rivals Ozempic in weight loss, sidesteps side effects

A Stanford Medicine study taps artificial intelligence to find a naturally occurring molecule called a peptide that suppressed appetite and led to weight loss in mice and pigs.

mednewsKrista Conger

Want to dive deeper on BRP and figure out what it is/how it works? If you'd like to read our analysis after Stanford's article above, the rest of this article is no longer available for free – if you'd like to read the rest of our analysis, check us out on Substack: